hotspot -WSS

hotspot

author：leisure time 2025-10-03 00:22:33 - browse：296

The Federal Trade Commission office glows softly inside, contrasting with the darkness outside — coverage from STAT — Adobe

Over the past two decades, hundreds of hospital mergers have escaped federal antitrust scrutiny and led to both higher prices and less competition, a new study shows.

But the study’s authors, and other researchers, believe the Federal Trade Commission’s hands often are tied. The agency simply doesn’t have enough money or people to crack down on all anticompetitive hospital deals, and some state laws shield hospital mergers from federal review completely.

“The resources available are just not commensurate with what the agency needs,” said Zack Cooper, an associate professor of health policy and economics at Yale University and one of the co-authors of the study. “This isn’t a story of the FTC not knowing what to do. I actually think they really know, very clearly, what to do. It’s a lack of resources, person power, and potentially willingness to do it.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： NIH documents show early flaws of $1.6 billion long Covid program

WSS

Congress must reauthorize a committee to support older Americans

Wegovy, Zepbound and weight loss drugs that preserve muscle

Cord blood banking comes at a high cost to babies

ASCO: Palliative care found as helpful given virtually as in person

Congress must reauthorize a committee to support older Americans

In key trial, Verve's treatment lowers cholesterol levels in patients

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Weight loss drug costs may need more research, senator suggests

Cancer drug shortages should be causing more outrage

Anthos stroke drug appears safer than common blood thinner

Duchenne breakthrough therapy leaves behind pioneering families

CRISPR pioneers react to Casgevy, first gene

Peter Hotez and the public health issue of online harassment

Change Healthcare can notify patients about the breach, HHS says

The high cost of giving birth even with insurance

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Wikipedia

Ionis drug prevents swelling attacks due to hereditary angioedema

Childhood cancer progress stalls for Black, Hispanic kids: Report

ASCO: Palliative care found as helpful given virtually as in person

Ransomware attacks on hospitals: Study outlines patient impact

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Childhood cancer progress stalls for Black, Hispanic kids: Report

leisure time

entertainment

explore

hotspot